Search For "infectious diseases"
Germany's 7-day COVID-19 incidence rises for 5th consecutive day
Updated : 4 years, 2 months ago IST
Berlin [Germany], January 3 (ANI/Xinhua): Germany's seven-day COVID-19 incidence rose for the fifth consecutive day, up from 222.7 on the previous day to 232.4, the Robert Koch Institute (RKI) for infectious diseases said on Monday.
Read More
Covovax authorisation is a vital step in India, where additional vaccine o
Updated : 4 years, 2 months ago IST
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Read More
Iran reports first case of COVID-19 Omicron variant
Updated : 4 years, 2 months ago IST
Tehran [Iran], December 19 (ANI/Xinhua): Iran identified the first case of the COVID-19 Omicron variant, Mohammad Mehdi Gooya, the head of management center of infectious diseases of Iran's Health Ministry, announced on Sunday.
Read More
Evidence suggests Omicron has 'increased infectivity' but no 'severe profi
Updated : 4 years, 3 months ago IST
Washington [US], December 8 (ANI): Amid the cloud of concerns regarding the Omicron coronavirus variant, National Institute of Allergy and Infectious Diseases Director Dr Anthony Fauci on Tuesday said emerging evidence suggests that Omicron has increased infectivity and not a "severe prof
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 3 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Covaxin 50 pc effective against symptomatic COVID: Lancet study
Updated : 4 years, 3 months ago IST
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Read More
Germany reports new record of nearly 53,000 daily COVID-19 cases
Updated : 4 years, 3 months ago IST
Berlin [Germany], November 17 (ANI/Xinhua): The number of daily COVID-19 cases in Germany hit a new record of 52,826, the Robert Koch Institute (RKI) for infectious diseases said Wednesday.
Read More
Germany's COVID-19 incidence rate highest since start of pandemic
Updated : 4 years, 4 months ago IST
Berlin [Germany], November 8 (ANI/Xinhua): Germany on Monday recorded the highest seven-day COVID-19 incidence rate since the start of the pandemic, the Robert Koch Institute (RKI) for infectious diseases said.
Read More
Large number of pharmaceutical consortiums to develop mRNA vaccine are bei
Updated : 4 years, 4 months ago IST
Seoul [South Korea], November 1 (ANI/Global Economic): A large number of consortiums of pharmaceutical-bio companies and research institutes to develop mRNA (messenger ribonucleic acid) vaccines are rapidly being established. As mRNA emerges as a new paradigm for vaccines, consortiums are ai
Read More
COVID-19 cases exceed 23,000 in Germany
Updated : 4 years, 4 months ago IST
Berlin [Germany], October 28 (ANI/Xinhua): The number of daily COVID-19 cases in Germany continued to rise significantly on Wednesday, as 23,212 new infections were registered in one day, around 6,200 more than a week ago, the Robert Koch Institute (RKI) for infectious diseases said on Wedne
Read More
Scientists find key to hepatitis C entry into cells, findings provide new
Updated : 4 years, 5 months ago IST
Washington [US], September 22 (ANI): Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe the structure of a key protein on the surface of the hepatitis C virus (HCV) and how it interacts with its receptor foun
Read More
Researchers develop new cell-analysis technique to fight tuberculosis
Updated : 4 years, 7 months ago IST
New York [US], July 23 (ANI): During a new study, researchers paved the way for new vaccine strategies against tuberculosis, and provided insights into fighting other infectious diseases around the world by analyzing how individual immune cells react to the bacterium that causes this deadly
Read More